サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1788347

スモールスケールバイオリアクターの世界市場

Small-Scale Bioreactors

出版日
ページ情報
英文 141 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.73円
スモールスケールバイオリアクターの世界市場
出版日: 2025年08月12日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 141 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

スモールスケールバイオリアクターの世界市場は2030年までに55億米ドルに達する

2024年に24億米ドルと推定されるスモールスケールバイオリアクターの世界市場は、2024年から2030年にかけてCAGR 14.8%で成長し、2030年には55億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである再利用可能バイオリアクターは、CAGR 12.9%を記録し、分析期間終了時には33億米ドルに達すると予測されます。シングルユース・バイオリアクター分野の成長率は、分析期間中CAGR17.8％と推定されます。

米国市場は6億3,210万米ドルと推定、中国はCAGR14.0％で成長予測

米国のスモールスケールバイオリアクター市場は、2024年には6億3,210万米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに8億5,440万米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは14.0%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ13.3％と12.9％と予測されています。欧州では、ドイツがCAGR 11.0%で成長すると予測されています。

世界のスモールスケールバイオリアクター市場- 主要動向と促進要因のまとめ

なぜスモールスケールバイオリアクターが重要性を増しているのか？バイオ医薬品およびバイオテクノロジー調査における役割の検証

バイオ医薬品、ワクチン、細胞ベースの治療に対する需要の高まりが、研究、プロセス最適化、初期段階の医薬品開発に重要な役割を果たすスモールスケールバイオリアクターの採用を後押ししています。大型の工業用バイオリアクターとは異なり、スモールスケールバイオリアクターは微生物、哺乳類細胞、その他の生物学的システムを数ミリリットルから数リットルの容量で培養するための制御された環境を提供します。これらのバイオリアクターは、バイオテクノロジーや製薬産業において、商業生産にスケールアップする前の細胞増殖条件を最適化するために不可欠です。学術機関、CRO（医薬品開発業務受託機関）、新興バイオテクノロジー企業も、大規模製造に関連するコストとリスクを軽減し、実験的研究を行うためにスモールスケールバイオリアクターを利用しています。精密医療、再生治療、合成生物学への投資が増加する中、効率的でスケーラブルなバイオプロセシングソリューションを求める企業のスモールスケールバイオリアクターへの需要は増加の一途をたどっています。

技術の進歩はスモールスケールバイオリアクターをどのように強化しているのか？自動化、モニタリング、プロセスコントロールにおける技術革新の探求

スモールスケールバイオリアクターにおける技術革新は、その効率性、再現性、自動化能力を著しく向上させています。光学センサーや分光学ベースの分析などのリアルタイムモニタリングシステムの統合により、研究者はpH、溶存酸素、栄養レベルなどの主要パラメーターを高精度で追跡することができます。人工知能（AI）や機械学習アルゴリズムを備えた自動制御システムは、バイオプロセス条件の適応的調整を可能にし、細胞培養のパフォーマンスを最適化します。さらに、シングルユース・バイオリアクターが人気を博しており、大規模な洗浄や滅菌の必要性を排除するとともに、交差汚染のリスクを低減しています。小型化された高スループット・バイオリアクターの開発は、研究をさらに加速し、複数のバイオプロセスパラメーターを同時に用いた並行実験を可能にしています。再現可能でスケーラブルなバイオプロセスへのニーズが高まる中、これらの進歩はバイオ医薬品製造の未来を形作るものであり、スモールスケールバイオリアクターは現代のバイオテクノロジー研究に欠かせないものとなっています。

スモールスケールバイオリアクター市場に影響を与える課題とは？コスト、スケーラビリティ、標準化の問題への対応

スモールスケールバイオリアクターは、採用が拡大しているにもかかわらず、コスト、スケーラビリティ、標準化に関する課題に直面しています。自動制御システムを備えた高度なバイオリアクターへの初期投資は高額になる可能性があり、小規模な研究所や新興バイオテクノロジー企業にとっては利用しやすい環境が制限されます。さらに、小規模生産から商業生産へのスケールアップは、スケールアップ中にバイオプロセス・パラメーターの再最適化が必要になることが多いため、依然として課題となっています。バイオリアクターの設計、特にシングルユースシステムには普遍的な標準がないため、異なるサプライヤーやバイオプロセスワークフロー間の互換性の問題も生じうる。さらに、自動化は効率を向上させるが、データの解釈やプロトコルの最適化には熟練者が必要であり、トレーニングの必要性が高まる。これらの課題に対処するためには、費用対効果の高い設計の継続的な革新、シームレスなスケールアップのためのバイオプロセスモデリングの改善、バイオリアクタープラットフォーム間の相互運用性を確保するための標準化への取り組みが必要です。

スモールスケールバイオリアクター市場の成長を促すものは何か？主な拡大要因と業界動向の特定

スモールスケールバイオリアクター市場の成長は、生物製剤や個別化医療に対する需要の増加、自動化技術の進歩、バイオ医薬品研究の拡大など、いくつかの要因によってもたらされています。高効率の上流バイオプロセスへのニーズの高まりにより、製薬企業はスケーラブルな少量生産モデルに投資するようになり、スモールスケールバイオリアクターの需要が増加しています。細胞ベースの治療、遺伝子治療、マイクロバイオーム研究の役割が拡大しているため、研究者は治療開発のために最適化された細胞培養環境を求めており、市場はさらに拡大しています。シングルユース・バイオリアクター技術の採用も市場拡大に寄与しており、初期段階のバイオ生産にコスト効率と柔軟性の高いソリューションを提供しています。バイオ医薬品の研究開発が成長を続ける中、スモールスケールバイオリアクターは医薬品開発、プロセス最適化、バイオ製造イノベーションの加速に重要な役割を果たすと期待されています。

セグメント

製品（リユーザブルバイオリアクター、シングルユースバイオリアクター）、エンドユーザー（製薬・バイオテクノロジー企業、CRO・CMO、学術・研究機関）

調査対象企業の例

  • American Alloy Fabricators Inc.
  • Applikon Biotechnology
  • Augusta Fiberglass
  • Bailun Biotech（Jiangsu）Co. LTD
  • Beckman Coulter, Inc.
  • BioNet
  • Biosan
  • Chemtrix BV
  • Corning Incorporated
  • Cytiva（formerly GE Healthcare Life Sciences）
  • Danaher Corporation
  • Eppendorf AG
  • Glen Mills, Inc.
  • GPC Bio
  • Hydro Engineering, Inc.
  • IKA Werke GmbH & Co. KG
  • INFORS HT
  • KNIK CO.,LTD.
  • Lee Industries, Inc.
  • Merck KGaA
  • Ollital Technology
  • Parr Instrument Company
  • Paul Mueller Company
  • PBS Biotech
  • Sartorius AG
  • Satake Martimics Co., Ltd.
  • Solaris Biotech
  • Solida Biotech
  • Thermo Fisher Scientific Inc.
  • VEOLIA WATER STI

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールにより、市場と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中のドメイン専門家からキュレートされたコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP32967

Global Small-Scale Bioreactors Market to Reach US$5.5 Billion by 2030

The global market for Small-Scale Bioreactors estimated at US$2.4 Billion in the year 2024, is expected to reach US$5.5 Billion by 2030, growing at a CAGR of 14.8% over the analysis period 2024-2030. Reusable Bioreactors, one of the segments analyzed in the report, is expected to record a 12.9% CAGR and reach US$3.3 Billion by the end of the analysis period. Growth in the Single-Use Bioreactors segment is estimated at 17.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$632.1 Million While China is Forecast to Grow at 14.0% CAGR

The Small-Scale Bioreactors market in the U.S. is estimated at US$632.1 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$854.4 Million by the year 2030 trailing a CAGR of 14.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 13.3% and 12.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 11.0% CAGR.

Global Small-Scale Bioreactors Market - Key Trends & Drivers Summarized

Why Are Small-Scale Bioreactors Gaining Importance? Examining Their Role in Biopharmaceutical and Biotech Research

The increasing demand for biopharmaceuticals, vaccines, and cell-based therapies has driven the adoption of small-scale bioreactors, which serve as critical tools for research, process optimization, and early-stage drug development. Unlike large industrial bioreactors, small-scale bioreactors provide a controlled environment for culturing microorganisms, mammalian cells, and other biological systems in volumes ranging from a few milliliters to several liters. These bioreactors are essential in the biotechnology and pharmaceutical industries for optimizing cell growth conditions before scaling up to commercial production. Academic institutions, contract research organizations (CROs), and startup biotech firms also rely on small-scale bioreactors to conduct experimental studies, reducing costs and risks associated with large-scale manufacturing. With increasing investment in precision medicine, regenerative therapies, and synthetic biology, the demand for small-scale bioreactors continues to rise as companies seek efficient and scalable bioprocessing solutions.

How Are Technological Advancements Enhancing Small-Scale Bioreactors? Exploring Innovations in Automation, Monitoring, and Process Control

Technological innovations in small-scale bioreactors have significantly improved their efficiency, reproducibility, and automation capabilities. The integration of real-time monitoring systems, such as optical sensors and spectroscopy-based analytics, allows researchers to track key parameters like pH, dissolved oxygen, and nutrient levels with high precision. Automated control systems with artificial intelligence (AI) and machine learning algorithms enable adaptive adjustments to bioprocess conditions, optimizing cell culture performance. Additionally, single-use bioreactors have gained popularity, eliminating the need for extensive cleaning and sterilization while reducing cross-contamination risks. The development of miniaturized, high-throughput bioreactors has further accelerated research, enabling parallel experimentation with multiple bioprocess parameters simultaneously. As the need for reproducible and scalable bioprocesses grows, these advancements are shaping the future of biopharmaceutical production, making small-scale bioreactors indispensable in modern biotech research.

What Challenges Are Impacting the Small-Scale Bioreactor Market? Addressing Cost, Scalability, and Standardization Issues

Despite their growing adoption, small-scale bioreactors face challenges related to cost, scalability, and standardization. The initial investment in advanced bioreactors equipped with automated control systems can be high, limiting accessibility for smaller research labs and emerging biotech firms. Additionally, scaling up from small-scale to commercial production remains a challenge, as bioprocess parameters often require re-optimization during scale-up. The lack of universal standards in bioreactor design, particularly for single-use systems, can also create compatibility issues between different suppliers and bioprocess workflows. Furthermore, while automation improves efficiency, it requires skilled personnel to interpret data and optimize protocols, increasing training requirements. Addressing these challenges involves continued innovation in cost-effective designs, improved bioprocess modeling for seamless scale-up, and standardization efforts to ensure interoperability across bioreactor platforms.

What’s Driving the Growth of the Small-Scale Bioreactors Market? Identifying Key Expansion Factors and Industry Trends

The growth in the small-scale bioreactors market is driven by several factors, including increasing demand for biologics and personalized medicine, advancements in automation technology, and the expansion of biopharmaceutical research. The rising need for high-efficiency upstream bioprocessing has led pharmaceutical companies to invest in scalable small-batch production models, increasing demand for small-scale bioreactors. The expanding role of cell-based therapies, gene therapies, and microbiome research has further strengthened the market as researchers seek optimized cell culture environments for therapeutic development. The adoption of single-use bioreactor technologies has also contributed to market expansion, offering cost-effective and flexible solutions for early-stage bioproduction. As biopharmaceutical R&D continues to grow, small-scale bioreactors are expected to play a crucial role in accelerating drug development, process optimization, and biomanufacturing innovation.

SCOPE OF STUDY:

The report analyzes the Small-Scale Bioreactors market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Reusable Bioreactors, Single-Use Bioreactors); End-User (Pharma & Biotech Companies, CROs & CMOs, Academic & Research Institutes)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 43 Featured) -

  • American Alloy Fabricators Inc.
  • Applikon Biotechnology
  • Augusta Fiberglass
  • Bailun Biotech (Jiangsu) Co. LTD
  • Beckman Coulter, Inc.
  • BioNet
  • Biosan
  • Chemtrix BV
  • Corning Incorporated
  • Cytiva (formerly GE Healthcare Life Sciences)
  • Danaher Corporation
  • Eppendorf AG
  • Glen Mills, Inc.
  • GPC Bio
  • Hydro Engineering, Inc.
  • IKA Werke GmbH & Co. KG
  • INFORS HT
  • KNIK CO.,LTD.
  • Lee Industries, Inc.
  • Merck KGaA
  • Ollital Technology
  • Parr Instrument Company
  • Paul Mueller Company
  • PBS Biotech
  • Sartorius AG
  • Satake Martimics Co., Ltd.
  • Solaris Biotech
  • Solida Biotech
  • Thermo Fisher Scientific Inc.
  • VEOLIA WATER STI

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Small-Scale Bioreactors - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Cell and Gene Therapy Research Throws the Spotlight on Small-Scale Bioreactor Adoption
    • Growth in R&D Labs and Academic Bioproduction Facilities Spurs Use of Miniaturized Bioprocessing Systems
    • OEM Innovation in Single-Use Bioreactor Formats With Integrated Sensors Enhances Usability and Data Precision
    • Expansion of Early-Stage Biologics and Biosimilar Development Drives Batch Flexibility in Small Volumes
    • OEM Focus on Plug-and-Play, Benchtop Bioreactor Designs Strengthens Decentralized Biomanufacturing
    • Increasing Demand for Parallel Processing and High-Throughput Screening Supports Multiplexed Reactor Systems
    • OEM Investment in Intelligent Control Systems and Real-Time Analytics Elevates Bioprocess Reproducibility
    • Surge in Microbial and Mammalian Cell Culture Applications Expands Segment-Specific Bioreactor Innovations
    • OEM Strategies for Disposable Bioreactor Liners and Modular Vessel Sizes Enhance Cost Efficiency
    • Rising Use of Small-Scale Reactors in Vaccine R&D Accelerates Turnaround and Risk Mitigation
    • OEM Collaboration With CDMOs, Startups, and Incubators Broadens Market Access to Flexible Bioreactor Platforms
    • Growth in Protein Expression Optimization and Media Screening Applications Spurs Product Customization
    • OEM Development of Scalable Bioreactor Platforms From 250ml to 10L Enhances Tech Transfer to GMP Settings
    • Increasing Use in Stem Cell Expansion, CAR-T Engineering, and Viral Vector Production Drives Precision Engineering
    • OEM Emphasis on GMP-Compatible, Closed System Designs Supports Early Clinical-Grade Bioprocessing
    • Rising Demand for Low-Shear Mixing and Gas Transfer Control Supports Viability of Fragile Cell Lines
    • OEM Introduction of Bioreactors With Wireless Connectivity and Cloud Monitoring Enhances Remote Oversight
    • Growth in Continuous and Perfusion Culture Protocols Fuels Innovation in Microfluidics and Control Parameters
    • OEM Focus on Low-Footprint, Self-Contained Units With Minimal Validation Burden Supports Academic and Field Labs
    • Focus on Cost-Effective, User-Friendly Systems Supports Entry-Level Biomanufacturing in Emerging Biotech Hubs
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Small-Scale Bioreactors Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Small-Scale Bioreactors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Small-Scale Bioreactors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Reusable Bioreactors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Reusable Bioreactors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Single-Use Bioreactors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Single-Use Bioreactors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for CROs & CMOs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for CROs & CMOs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Academic & Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Small-Scale Bioreactors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 14: USA Recent Past, Current & Future Analysis for Small-Scale Bioreactors by Product - Reusable Bioreactors and Single-Use Bioreactors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 15: USA 6-Year Perspective for Small-Scale Bioreactors by Product - Percentage Breakdown of Value Sales for Reusable Bioreactors and Single-Use Bioreactors for the Years 2025 & 2030
    • TABLE 16: USA Recent Past, Current & Future Analysis for Small-Scale Bioreactors by End-user - Pharma & Biotech Companies, CROs & CMOs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 17: USA 6-Year Perspective for Small-Scale Bioreactors by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, CROs & CMOs and Academic & Research Institutes for the Years 2025 & 2030
  • CANADA
    • TABLE 18: Canada Recent Past, Current & Future Analysis for Small-Scale Bioreactors by Product - Reusable Bioreactors and Single-Use Bioreactors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 19: Canada 6-Year Perspective for Small-Scale Bioreactors by Product - Percentage Breakdown of Value Sales for Reusable Bioreactors and Single-Use Bioreactors for the Years 2025 & 2030
    • TABLE 20: Canada Recent Past, Current & Future Analysis for Small-Scale Bioreactors by End-user - Pharma & Biotech Companies, CROs & CMOs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 21: Canada 6-Year Perspective for Small-Scale Bioreactors by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, CROs & CMOs and Academic & Research Institutes for the Years 2025 & 2030
  • JAPAN
    • Small-Scale Bioreactors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 22: Japan Recent Past, Current & Future Analysis for Small-Scale Bioreactors by Product - Reusable Bioreactors and Single-Use Bioreactors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 23: Japan 6-Year Perspective for Small-Scale Bioreactors by Product - Percentage Breakdown of Value Sales for Reusable Bioreactors and Single-Use Bioreactors for the Years 2025 & 2030
    • TABLE 24: Japan Recent Past, Current & Future Analysis for Small-Scale Bioreactors by End-user - Pharma & Biotech Companies, CROs & CMOs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 25: Japan 6-Year Perspective for Small-Scale Bioreactors by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, CROs & CMOs and Academic & Research Institutes for the Years 2025 & 2030
  • CHINA
    • Small-Scale Bioreactors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 26: China Recent Past, Current & Future Analysis for Small-Scale Bioreactors by Product - Reusable Bioreactors and Single-Use Bioreactors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: China 6-Year Perspective for Small-Scale Bioreactors by Product - Percentage Breakdown of Value Sales for Reusable Bioreactors and Single-Use Bioreactors for the Years 2025 & 2030
    • TABLE 28: China Recent Past, Current & Future Analysis for Small-Scale Bioreactors by End-user - Pharma & Biotech Companies, CROs & CMOs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 29: China 6-Year Perspective for Small-Scale Bioreactors by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, CROs & CMOs and Academic & Research Institutes for the Years 2025 & 2030
  • EUROPE
    • Small-Scale Bioreactors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 30: Europe Recent Past, Current & Future Analysis for Small-Scale Bioreactors by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 31: Europe 6-Year Perspective for Small-Scale Bioreactors by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 32: Europe Recent Past, Current & Future Analysis for Small-Scale Bioreactors by Product - Reusable Bioreactors and Single-Use Bioreactors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Europe 6-Year Perspective for Small-Scale Bioreactors by Product - Percentage Breakdown of Value Sales for Reusable Bioreactors and Single-Use Bioreactors for the Years 2025 & 2030
    • TABLE 34: Europe Recent Past, Current & Future Analysis for Small-Scale Bioreactors by End-user - Pharma & Biotech Companies, CROs & CMOs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 35: Europe 6-Year Perspective for Small-Scale Bioreactors by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, CROs & CMOs and Academic & Research Institutes for the Years 2025 & 2030
  • FRANCE
    • Small-Scale Bioreactors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 36: France Recent Past, Current & Future Analysis for Small-Scale Bioreactors by Product - Reusable Bioreactors and Single-Use Bioreactors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 37: France 6-Year Perspective for Small-Scale Bioreactors by Product - Percentage Breakdown of Value Sales for Reusable Bioreactors and Single-Use Bioreactors for the Years 2025 & 2030
    • TABLE 38: France Recent Past, Current & Future Analysis for Small-Scale Bioreactors by End-user - Pharma & Biotech Companies, CROs & CMOs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: France 6-Year Perspective for Small-Scale Bioreactors by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, CROs & CMOs and Academic & Research Institutes for the Years 2025 & 2030
  • GERMANY
    • Small-Scale Bioreactors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 40: Germany Recent Past, Current & Future Analysis for Small-Scale Bioreactors by Product - Reusable Bioreactors and Single-Use Bioreactors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 41: Germany 6-Year Perspective for Small-Scale Bioreactors by Product - Percentage Breakdown of Value Sales for Reusable Bioreactors and Single-Use Bioreactors for the Years 2025 & 2030
    • TABLE 42: Germany Recent Past, Current & Future Analysis for Small-Scale Bioreactors by End-user - Pharma & Biotech Companies, CROs & CMOs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 43: Germany 6-Year Perspective for Small-Scale Bioreactors by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, CROs & CMOs and Academic & Research Institutes for the Years 2025 & 2030
  • ITALY
    • TABLE 44: Italy Recent Past, Current & Future Analysis for Small-Scale Bioreactors by Product - Reusable Bioreactors and Single-Use Bioreactors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Italy 6-Year Perspective for Small-Scale Bioreactors by Product - Percentage Breakdown of Value Sales for Reusable Bioreactors and Single-Use Bioreactors for the Years 2025 & 2030
    • TABLE 46: Italy Recent Past, Current & Future Analysis for Small-Scale Bioreactors by End-user - Pharma & Biotech Companies, CROs & CMOs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 47: Italy 6-Year Perspective for Small-Scale Bioreactors by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, CROs & CMOs and Academic & Research Institutes for the Years 2025 & 2030
  • UNITED KINGDOM
    • Small-Scale Bioreactors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 48: UK Recent Past, Current & Future Analysis for Small-Scale Bioreactors by Product - Reusable Bioreactors and Single-Use Bioreactors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 49: UK 6-Year Perspective for Small-Scale Bioreactors by Product - Percentage Breakdown of Value Sales for Reusable Bioreactors and Single-Use Bioreactors for the Years 2025 & 2030
    • TABLE 50: UK Recent Past, Current & Future Analysis for Small-Scale Bioreactors by End-user - Pharma & Biotech Companies, CROs & CMOs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: UK 6-Year Perspective for Small-Scale Bioreactors by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, CROs & CMOs and Academic & Research Institutes for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 52: Rest of Europe Recent Past, Current & Future Analysis for Small-Scale Bioreactors by Product - Reusable Bioreactors and Single-Use Bioreactors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 53: Rest of Europe 6-Year Perspective for Small-Scale Bioreactors by Product - Percentage Breakdown of Value Sales for Reusable Bioreactors and Single-Use Bioreactors for the Years 2025 & 2030
    • TABLE 54: Rest of Europe Recent Past, Current & Future Analysis for Small-Scale Bioreactors by End-user - Pharma & Biotech Companies, CROs & CMOs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 55: Rest of Europe 6-Year Perspective for Small-Scale Bioreactors by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, CROs & CMOs and Academic & Research Institutes for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Small-Scale Bioreactors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 56: Asia-Pacific Recent Past, Current & Future Analysis for Small-Scale Bioreactors by Product - Reusable Bioreactors and Single-Use Bioreactors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Asia-Pacific 6-Year Perspective for Small-Scale Bioreactors by Product - Percentage Breakdown of Value Sales for Reusable Bioreactors and Single-Use Bioreactors for the Years 2025 & 2030
    • TABLE 58: Asia-Pacific Recent Past, Current & Future Analysis for Small-Scale Bioreactors by End-user - Pharma & Biotech Companies, CROs & CMOs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 59: Asia-Pacific 6-Year Perspective for Small-Scale Bioreactors by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, CROs & CMOs and Academic & Research Institutes for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 60: Rest of World Recent Past, Current & Future Analysis for Small-Scale Bioreactors by Product - Reusable Bioreactors and Single-Use Bioreactors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 61: Rest of World 6-Year Perspective for Small-Scale Bioreactors by Product - Percentage Breakdown of Value Sales for Reusable Bioreactors and Single-Use Bioreactors for the Years 2025 & 2030
    • TABLE 62: Rest of World Recent Past, Current & Future Analysis for Small-Scale Bioreactors by End-user - Pharma & Biotech Companies, CROs & CMOs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Rest of World 6-Year Perspective for Small-Scale Bioreactors by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, CROs & CMOs and Academic & Research Institutes for the Years 2025 & 2030

IV. COMPETITION